Evaluation of the Clinical Effects and Frequency of MEFV Gene Mutation in Patients with Inflammatory Bowel Disease

CONCLUSION: The rate of MEFV gene mutations was high in patients with UC who required surgery. These patients have frequent and severe attacks, indicating that the mutations are related to disease severity. MEFV mutation as a modifier factor of IBD should be considered.PMID:34819953 | PMC:PMC8608532 | DOI:10.1155/2021/5538150
Source: Gastroenterology Research and Practice - Category: Gastroenterology Authors: Source Type: research

Related Links:

Am J Transl Res. 2021 Dec 15;13(12):13916-13930. eCollection 2021.ABSTRACTInflammatory bowel diseases are chronic illnesses that involve intestinal inflammation and are usually diagnosed as Crohn's disease or ulcerative colitis. As these diseases do not have a cure, the goal of treatment is to induce and maintain remission. Monoclonal antibodies have been recognized as the most advanced therapy to avoid complications and reduce the need for surgical approaches. However, although their effectiveness has been proven by several studies, they can trigger the immune system, induce the occurrence of immunogenicity, which may lea...
Source: American Journal of Translational Research - Category: Research Authors: Source Type: research
This study was performed to investigate the clinical roles of PR3-ANCAs in the disease severity, disease extension, and clinical course of UC.METHODS: Serum PR3-ANCAs were measured in 173 UC patients including 77 patients with new-onset patients UC diagnosed within 1 month, 110 patients with Crohn's disease, 48 patients with other intestinal diseases, and 71 healthy controls. Associations between the PR3-ANCA titer and clinical data, such as disease severity, disease extension, and clinical course, were assessed. The clinical utility of PR3-ANCA measurement was evaluated by receiver operating characteristic (ROC) analysis....
Source: Gut and Liver - Category: Gastroenterology Authors: Source Type: research
Rom J Morphol Embryol. 2021 Apr-Jun;62(2):395-400. doi: 10.47162/RJME.62.2.05.ABSTRACTUlcerative colitis and Crohn's disease are the inflammatory bowel diseases with a continuously increasing of prevalence. Their exact causes are still not well known and, more than that, they are raising up serious issues of diagnosis. The same difficulties of diagnosis are encountered in the case of the colonic angiodysplasia or ischemic colitis (IC). Colonic angiodysplasia is a common vascular abnormality of the gastrointestinal tract, being diagnosed mostly in the elderly persons, in a similar manner to the IC. For all these diseases co...
Source: Romanian Journal of Morphology and Embryology - Category: General Medicine Authors: Source Type: research
Conditions:   Ulcerative Colitis Chronic;   Crohn Disease Colon Intervention:   Other: No intervention Sponsors:   Kazakhstan Scientific Society for Study of intestine diseases;   FERRING Kazakhstan Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
CONCLUSIONS: available objective data to guide nutritional support and primary nutritional therapy in IBD are presented as 64 recommendations, of which 9 are very strong recommendations (grade A), 22 are strong recommendations (grade B), and 12 are based only on sparse evidence (grade 0); 21 recommendations are good practice points (GPP).PMID:35014851 | DOI:10.20960/nh.03857
Source: Nutricion Hospitalaria - Category: Nutrition Authors: Source Type: research
CONCLUSIONS: Roux-en-Y gastric bypass was associated with increased risk of Crohn's disease and unclassified inflammatory bowel disease, whereas sleeve gastrectomy was associated with increased risk of ulcerative colitis only.PMID:35012883 | DOI:10.1016/j.soard.2021.12.014
Source: Surgery for Obesity and Related Diseases : official journal of the American Society for Bariatric Surgery - Category: Surgery Authors: Source Type: research
We examined whether relationships between known risk factors for Crohn ’s disease (CD) and ulcerative colitis (UC) differ according to disease phenotype, defined by Montreal classification, at the time of diagnosis.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Source Type: research
Eur J Pharm Sci. 2022 Jan 7:106122. doi: 10.1016/j.ejps.2022.106122. Online ahead of print.ABSTRACTInflammatory bowel disease (IBD), which is a chronic inflammatory disease of the gastrointestinal system, has two subtypes: Ulcerative Colitis (UC) and Crohn's Disease (CD). Only pH-sensitive drug delivery systems are commonly utilized for the treatment of IBD, but their effectiveness is frequently obstructed by the change in intestinal pH. To overcome the inadequacy of only pH-dependent delivery systems, we developed in vitro evaluated both pH- and time-dependent nanoparticles loaded budesonide (BUD) for the treatment of IBD...
Source: European Journal of Pharmaceutical Sciences - Category: Drugs & Pharmacology Authors: Source Type: research
Bioinform Biol Insights. 2021 Dec 22;15:11779322211055285. doi: 10.1177/11779322211055285. eCollection 2021.ABSTRACTBACKGROUND: Inflammatory bowel diseases (IBDs) are complex, multifactorial disorders that comprise Crohn's disease (CD) and ulcerative colitis (UC). Recent discoveries have brought much attention to the genetic predisposition of patients with IBD. Here we evaluate the interaction between IBD genetic risk factors susceptibility and CD occurrence in an IBD pediatric patient population, performing a clinical exome survey.METHODS: From February 2018 to April 2019, we collected blood samples from 7 pediatric patie...
Source: Bioinformatics and Biology Insights - Category: Bioinformatics Authors: Source Type: research
More News: Crohn's Disease | Gastroenterology | Genetics | Inflammatory Bowel Disease | Ulcerative Colitis